« PLx Pharma raises $6,100,000
Active Response Group raises $10,000,000 »

Sirion Therapeutics raises $45,000,000

April 9, 2007
 VCA Theme: Ophthalmic Diseases

Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical company, announced today that it has raised $45 million in a Series B private equity financing